This site is intended for healthcare professionals only

Analysis supports increasing retinopathy screening interval in type 2 diabetes beyond 12 months

A 4-year retrospective analysis of community screening for diabetic retinopathy in Wales supports the extension of the current 12-month screening interval for people with type 2 diabetes, except those treated with insulin who have had diabetes for 10 years or more.

The investigators analysed data from over 57 000 people with type 2 diabetes diagnosed at age 30 years or older and who had no evidence of diabetic retinopathy at their first screening event between 2005 and 2009. 

Publishing their findings in the BMJ, they found that the annual incidence of any retinopathy fell from 124.94 to 66.59 per 1000 people over the 4 year study period, whereas referable retinopathy rates increased slightly from 2.02 to 3.54 per 1000 people. For the subset of patients treated with insulin who had had diabetes for ≥10 years, the incidence of referable retinopathy at 1 and 4 years was 9.61 and 30.99 per 1000 people, respectively.

Click here to access the paper in full

Related content
Digital eye screening to be available in the community
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.